Dr. George Diaz discusses fight to mitigate mutated coronavirus

Share this Article
Facebook
Twitter
LinkedIn

As it reaches the one year mark since the first COVID-19 patient was hospitalized in the United States, the U.S. is bracing as a potentially more contagious strain of the coronavirus is possibly spreading. Dr. George Diaz, who treated the first patient at Providence Regional Medical Center, spoke with NewsNation Now on this new strain and the fight to contain it.

“It’s highly concerning that we have this strain in the U.S., but it’s not a surprise,” Diaz said. “It has a number of mutations that make it easier to infect humans.”

Other content in this Stream

Drawing on patient experiences, Providence study identifies four categories of long COVID and reveals importance of whole-person care

Dr. George Diaz discusses fight to mitigate mutated coronavirus

About the Author

Previous Article

Next Article

Other content in this Stream

Providence study seeks to help practitioners better identify and care for patients by providing a more comprehensive understanding of how long COVID presents and the patient experience of this disease

A new study published in the Transplant Infectious Diseases could provide help for the shortage of donated organs by using an organs from a SARS-CoV-2-positive donor.

A Providence study released online in the Journal of the American Medical Association sheds new light on the added benefit of a booster dose of a COVID-19 mRNA vaccine among previously vaccinated.

Institute for Systems Biology-led study finds several warning factors.

ISB-led study shows unvaccinated pregnant people with COVID-19 are more likely to have poor birth outcomes even if they did not experience severe respiratory problems during infection.

Providence offers $1,000 recognition bonus to all caregivers and works to rapidly fill open positions.

Remdesivir use is associated with lower mortality compared to best supportive care.

Providence published findings today in the Journal of the American Medical Association that demonstrate the rarity of myocarditis and pericarditis occurring post COVID-19 vaccination.

Providence offers insights about the FDA's approval of the COVID-19 vaccine for 12-15-year-olds.

Still undecided about the efficacy of the COVID vaccine? Here are 5 facts that we hope will help you decide. Learn more.

Providence's Dr. Amy Compton-Phillips talks about her journey and how she evolved as a national leader in transforming healthcare.

It’s important during Women’s Health Week to take a moment to schedule your next doctor’s appointment.

President and CEO of Providence joined with other CEOs from across the United States to set new standards of safety for health care workers.

FierceHealthcare has named Providence's Dr. George Diaz as one of 2021's Most Influential Minority Executives in Health Care.

Providence is proud to announce its latest spin out, DexCare. This is the third company to spin out of Providence’s Digital Innovation Group in the last seven years.

Providence Chief Medical Analytics Officer, Dr. Ari Robicsek offers insights on how pandemic created innovations in care delivery.

Drs. Rhonda Medows and Amy Compton-Phillips were recognized by Modern Healthcare as two of 2021’s Top 25 Women Leaders.

Rod Hochman, M.D. speaks on the announcement of 14 leading health systems joining forces to form a new data consortium, Truveta.

Providence's President Lisa Vance shares how the community is coming together to support the COVID-19 crisis in California. Learn more.

Providence’s ambulatory care network and physician enterprise groups will be integrated with other clinical functions.